These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9885715)

  • 1. Issues in peripheral blood stem cell transplantation.
    Lim HL; Lee SH
    Singapore Med J; 1998 Sep; 39(9):388-9. PubMed ID: 9885715
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral blood stem cell transplants.
    Raina V
    Natl Med J India; 1995; 8(6):251-4. PubMed ID: 8520441
    [No Abstract]   [Full Text] [Related]  

  • 3. The principles and overview of autologous hematopoietic stem cell transplantation.
    Vaughan W; Seshadri T; Bridges M; Keating A
    Cancer Treat Res; 2009; 144():23-45. PubMed ID: 19779877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent progress on peripheral blood stem cell transplantation].
    Harada M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):605. PubMed ID: 8963761
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
    Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
    Bone Marrow Transplant; 2006 Mar; 37(5):439-49. PubMed ID: 16444286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematopoietic stem cell transplantation].
    Dalle JH
    Soins Pediatr Pueric; 2009 Dec; (251):23-4. PubMed ID: 19994711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hematopoietic stem cell transplantation].
    Sato N
    Rinsho Byori; 2001 Mar; Suppl 115():103-10. PubMed ID: 11391926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of different hematopoietic stem cell sources (primed marrow, mobilized blood, and steady-state marrow) in autologous and allogenic transplantation.
    Chiang KY; Worthington-White D
    Exp Hematol; 2004 Aug; 32(8):698-9. PubMed ID: 15308319
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation activity in Europe 1999.
    Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
    Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of stem cell transplantation.
    Harousseau JL
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic stem cell transplantation].
    Sakamaki H
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():488-93. PubMed ID: 17474453
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous peripheral blood stem cell transplantation in childhood tumors.
    Kalmanti M; Stiakaki E
    Pediatr Hematol Oncol; 1999; 16(4):277-81. PubMed ID: 10407862
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease.
    Tey S; Butler J; Durrant S; Hill G; Morton J; Kennedy G
    Bone Marrow Transplant; 2005 Sep; 36(6):553-4; author reply 554. PubMed ID: 16044146
    [No Abstract]   [Full Text] [Related]  

  • 18. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.